| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,021 |
16,278 |
$4.43M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,467 |
26,786 |
$4.18M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,399 |
3,744 |
$1.30M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,318 |
6,780 |
$1.21M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,387 |
6,739 |
$494K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,258 |
8,794 |
$468K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
853 |
796 |
$467K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,107 |
5,112 |
$263K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,167 |
8,395 |
$197K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,249 |
6,379 |
$191K |
| 80053 |
Comprehensive metabolic panel |
20,303 |
17,243 |
$177K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,308 |
19,006 |
$171K |
| 71045 |
Radiologic examination, chest; single view |
6,333 |
5,437 |
$171K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,063 |
922 |
$160K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,478 |
5,536 |
$117K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
645 |
560 |
$90K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,627 |
3,084 |
$81K |
| J3490 |
Unclassified drugs |
62,340 |
28,994 |
$75K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,954 |
3,480 |
$54K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,441 |
3,865 |
$52K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,178 |
5,261 |
$48K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
720 |
645 |
$45K |
| 81025 |
|
5,886 |
5,016 |
$42K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,126 |
1,993 |
$40K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
223 |
207 |
$39K |
| 71046 |
Radiologic examination, chest; 2 views |
1,418 |
1,204 |
$39K |
| 87430 |
|
2,697 |
2,411 |
$37K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
9,380 |
7,889 |
$35K |
| D0272 |
Bitewings - two radiographic images |
175 |
166 |
$30K |
| 83735 |
|
4,762 |
4,114 |
$28K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
465 |
393 |
$28K |
| 87070 |
|
2,440 |
2,173 |
$24K |
| 83690 |
|
3,676 |
3,097 |
$23K |
| 81001 |
|
5,551 |
5,120 |
$19K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
246 |
146 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
590 |
360 |
$16K |
| D7140 |
Extraction, erupted tooth or exposed root |
95 |
88 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,140 |
1,897 |
$15K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
927 |
813 |
$14K |
| 84484 |
|
1,696 |
1,154 |
$13K |
| 81003 |
|
4,313 |
3,885 |
$11K |
| 84703 |
|
1,035 |
947 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
151 |
123 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
349 |
288 |
$10K |
| J2704 |
Injection, propofol, 10 mg |
475 |
445 |
$8K |
| D0220 |
Intraoral - periapical first radiographic image |
56 |
54 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
607 |
569 |
$5K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
96 |
79 |
$5K |
| D1351 |
Sealant - per tooth |
40 |
39 |
$5K |
| D1120 |
Prophylaxis - child |
37 |
37 |
$5K |
| 87631 |
|
85 |
51 |
$4K |
| D0230 |
Intraoral - periapical each additional radiographic image |
26 |
26 |
$4K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
34 |
32 |
$4K |
| 80299 |
|
238 |
193 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
12 |
12 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
147 |
138 |
$3K |
| D1206 |
Topical application of fluoride varnish |
26 |
25 |
$3K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
20 |
19 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
134 |
128 |
$2K |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
121 |
117 |
$2K |
| 94060 |
|
65 |
63 |
$2K |
| 94729 |
|
64 |
62 |
$2K |
| 85027 |
|
141 |
130 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
59 |
52 |
$890.85 |
| 94726 |
|
63 |
62 |
$832.30 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
36 |
12 |
$807.80 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
28 |
27 |
$797.95 |
| 74018 |
|
25 |
12 |
$681.72 |
| 80143 |
|
112 |
100 |
$675.67 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25 |
24 |
$672.32 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
35 |
34 |
$587.62 |
| 84443 |
Thyroid stimulating hormone (TSH) |
28 |
24 |
$550.06 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$366.72 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,465 |
980 |
$356.73 |
| 80061 |
Lipid panel |
13 |
12 |
$288.10 |
| 85379 |
|
26 |
24 |
$273.28 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
17 |
12 |
$258.26 |
| 85610 |
|
75 |
65 |
$255.08 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
36 |
26 |
$230.16 |
| 82550 |
|
45 |
40 |
$211.53 |
| 80179 |
|
112 |
100 |
$174.14 |
| 87420 |
|
12 |
12 |
$171.36 |
| 83880 |
|
13 |
12 |
$169.20 |
| 80076 |
|
13 |
12 |
$141.80 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
2,604 |
2,247 |
$101.66 |
| 87186 |
|
13 |
13 |
$98.70 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
17 |
12 |
$32.09 |
| 87486 |
|
17 |
12 |
$32.09 |
| 87581 |
|
17 |
12 |
$32.09 |
| J7510 |
Prednisolone oral, per 5 mg |
38 |
36 |
$2.60 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
87 |
84 |
$1.41 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
13 |
$0.69 |